表观遗传学
生物
染色质
前列腺癌
癌症研究
遗传异质性
神经内分泌分化
前列腺
神经内分泌细胞
神经内分泌肿瘤
转录因子
癌症
遗传学
基因
免疫组织化学
免疫学
表型
内分泌学
作者
Paloma Cejas,Yingtian Xie,Alba Font‐Tello,Klothilda Lim,Sudeepa Syamala,Xintao Qiu,Alok K. Tewari,Neel Shah,Holly M. Nguyen,Radhika A. Patel,Lisha G. Brown,Ilsa M. Coleman,Wenzel M. Hackeng,Lodewijk A.A. Brosens,Koen M.A. Dreijerink,Leigh Ellis,Sarah Abou Alaiwi,Ji-Heui Seo,Sylvan C. Baca,Himisha Beltran
标识
DOI:10.1038/s41467-021-26042-z
摘要
Neuroendocrine carcinomas (NEC) are tumors expressing markers of neuronal differentiation that can arise at different anatomic sites but have strong histological and clinical similarities. Here we report the chromatin landscapes of a range of human NECs and show convergence to the activation of a common epigenetic program. With a particular focus on treatment emergent neuroendocrine prostate cancer (NEPC), we analyze cell lines, patient-derived xenograft (PDX) models and human clinical samples to show the existence of two distinct NEPC subtypes based on the expression of the neuronal transcription factors ASCL1 and NEUROD1. While in cell lines and PDX models these subtypes are mutually exclusive, single-cell analysis of human clinical samples exhibits a more complex tumor structure with subtypes coexisting as separate sub-populations within the same tumor. These tumor sub-populations differ genetically and epigenetically contributing to intra- and inter-tumoral heterogeneity in human metastases. Overall, our results provide a deeper understanding of the shared clinicopathological characteristics shown by NECs. Furthermore, the intratumoral heterogeneity of human NEPCs suggests the requirement of simultaneous targeting of coexisting tumor populations as a therapeutic strategy.
科研通智能强力驱动
Strongly Powered by AbleSci AI